4D Molecular Cash Over Time
| FDMT Stock | USD 7.79 0.20 2.50% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out 4D Molecular Performance and 4D Molecular Correlation. FDMT |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of 4D Molecular. If investors know FDMT will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about 4D Molecular listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.85) | Quarterly Revenue Growth (1.00) | Return On Assets (0.17) | Return On Equity (0.24) |
The market value of 4D Molecular Therapeutics is measured differently than its book value, which is the value of FDMT that is recorded on the company's balance sheet. Investors also form their own opinion of 4D Molecular's value that differs from its market value or its book value, called intrinsic value, which is 4D Molecular's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because 4D Molecular's market value can be influenced by many factors that don't directly affect 4D Molecular's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between 4D Molecular's value and its price as these two are different measures arrived at by different means. Investors typically determine if 4D Molecular is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, 4D Molecular's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Cash Analysis
Compare 4D Molecular Therapeutics and related stocks such as Tcr2 Therapeutics, Revolution Medicines, and Black Diamond Therap Cash Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RVMD | 9.1 M | 9.1 M | 9.1 M | 9.1 M | 9.1 M | 9.1 M | 9.1 M | 9.1 M | 69.6 M | 16.7 M | 104.3 M | 108.5 M | 161.4 M | 696.1 M | 731 M |
| BDTX | 7.9 M | 7.9 M | 7.9 M | 7.9 M | 7.9 M | 7.9 M | 7.9 M | 7.9 M | 51.7 M | 154.7 M | 34.6 M | 65.8 M | 34.3 M | 56.2 M | 63.7 M |
| PASG | 24.9 M | 24.9 M | 24.9 M | 24.9 M | 24.9 M | 24.9 M | 24.9 M | 24.9 M | 24.9 M | 158.9 M | 135 M | 129 M | 34.6 M | 21.7 M | 20.6 M |
| IPSC | 208 K | 208 K | 208 K | 208 K | 208 K | 208 K | 21.5 M | 44.1 M | 44.1 M | 44.1 M | 27.2 M | 56.4 M | 84.3 M | 47.3 M | 44.2 M |
| EWTX | 23.7 M | 23.7 M | 23.7 M | 23.7 M | 23.7 M | 23.7 M | 23.7 M | 23.7 M | 23.7 M | 23.7 M | 104.9 M | 280.8 M | 351.9 M | 86.1 M | 81.8 M |
| CCCC | 36.3 M | 36.3 M | 36.3 M | 36.3 M | 36.3 M | 36.3 M | 36.3 M | 36.3 M | 36.3 M | 90.5 M | 181.7 M | 76.1 M | 29.8 M | 126.6 M | 99.2 M |
| MLYS | 1.4 M | 1.4 M | 1.4 M | 1.4 M | 1.4 M | 1.4 M | 1.4 M | 1.4 M | 1.4 M | 1.4 M | 1.4 M | 10.6 M | 87.7 M | 49.3 M | 41 M |
| CGEM | 2.3 K | 2.3 K | 2.3 K | 2.3 K | 2.2 K | 118 | 91.0 | 33.8 M | 33.8 M | 63.2 M | 168.2 M | 430.9 M | 550.1 M | 98.4 M | 147.9 M |
| BMEA | 239 K | 239 K | 239 K | 239 K | 239 K | 239 K | 239 K | 239 K | 239 K | 239 K | 61.7 M | 175.7 M | 113.4 M | 176.9 M | 116.1 M |
| STOK | 1.8 M | 1.8 M | 1.8 M | 1.8 M | 1.8 M | 1.8 M | 1.8 M | 1.8 M | 105.4 M | 222.5 M | 287.3 M | 144.9 M | 113.6 M | 191.4 M | 167.7 M |
| AKRO | 598 K | 598 K | 598 K | 598 K | 598 K | 598 K | 598 K | 598 K | 76 M | 136.4 M | 187.2 M | 150.5 M | 249.8 M | 234.2 M | 162.6 M |
| GOSS | 60 K | 60 K | 60 K | 60 K | 60 K | 60 K | 60 K | 315 K | 105.2 M | 135.1 M | 486.1 M | 183.4 M | 112 M | 32.1 M | 30.5 M |
| REPL | 20.6 M | 20.6 M | 20.6 M | 20.6 M | 20.6 M | 20.6 M | 20.6 M | 17.6 M | 25.7 M | 59.5 M | 182.5 M | 105.9 M | 146.6 M | 74.5 M | 87 M |
| NVCT | 5.7 M | 5.7 M | 5.7 M | 5.7 M | 5.7 M | 5.7 M | 5.7 M | 5.7 M | 5.7 M | 5.7 M | 5.7 M | 5.7 M | 20 M | 19.1 M | 13.9 M |
| LYRA | 23.9 M | 23.9 M | 23.9 M | 23.9 M | 23.9 M | 23.9 M | 23.9 M | 23.9 M | 23.9 M | 9.8 M | 74.6 M | 45.7 M | 32.5 M | 22.4 M | 38.3 M |
| KRON | 10.2 M | 10.2 M | 10.2 M | 10.2 M | 10.2 M | 10.2 M | 10.2 M | 10.2 M | 10.2 M | 32.6 M | 462.1 M | 339.5 M | 76 M | 64.3 M | 61.1 M |
4D Molecular Therapeutics and related stocks such as Tcr2 Therapeutics, Revolution Medicines, and Black Diamond Therap Cash description
Cash refers to the most liquid asset of 4D Molecular Therapeutics, which is listed under current asset account on 4D Molecular Therapeutics balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from 4D Molecular customers. The amounts must be unrestricted with restricted cash listed in a different 4D Molecular account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.My Equities
My Current Equities and Potential Positions
| 4D Molecular Therapeutics | FDMT |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | California; U.S.A |
| Exchange | NASDAQ Exchange |
USD 7.79
Additional Tools for FDMT Stock Analysis
When running 4D Molecular's price analysis, check to measure 4D Molecular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 4D Molecular is operating at the current time. Most of 4D Molecular's value examination focuses on studying past and present price action to predict the probability of 4D Molecular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 4D Molecular's price. Additionally, you may evaluate how the addition of 4D Molecular to your portfolios can decrease your overall portfolio volatility.